Office of the Director, Office of Science Policy, Office of Biotechnology Activities; Notice of Meeting, 76995-76996 [2015-31238]

Download as PDF jstallworth on DSK7TPTVN1PROD with NOTICES Federal Register / Vol. 80, No. 238 / Friday, December 11, 2015 / Notices that the applicant has the necessary credentials to order and certify certain Medicare items and services or to prescribe Medicare Part D drugs. This includes ensuring that the physician is not excluded debarred from the Medicare program. Form Number: CMS–855O (OMB Control Number: 0938–1135); Frequency: Occasionally; Affected Public: Private Sector (Business or other for-profits), State, Local, or Tribal Governments; Number of Respondents: 448,000; Number of Responses: 24,000; Total Annual Hours: 243,600. (For questions regarding this collection contact Kimberly McPhillips (410) 786–8438.) 2. Type of Information Collection Request: Revision of a currently approved information collection; Title of Information Collection: Data Collection to Support Eligibility Determinations and Enrollment for Employees in the Small Business Health Options Program; Use: Section 1311(b)(1)(B) of the Affordable Care Act directs that the SHOP assist qualified small employers in facilitating the enrollment of their employees in QHPs offered in the small group market. Section 1311(c)(1)(F) of the Affordable Care Act directs HHS to establish criteria for certification of health plans as QHPs and plans to utilize a uniform enrollment form for qualified employers. Further, section 1311(c)(5)(B) directs HHS to develop a Web site that assists employers in determining if they are eligible to participate in SHOP. Form Number: CMS–10438 (OMB Control Number: 0938–1194); Frequency: Annually; Affected Public: Private Sector; Number of Respondents: 60,000; Number of Responses: 60,000; Total Annual Hours: 60,000. (For questions regarding this collection contact Christelle Jang at (410) 786–8438.) 3. Type of Information Collection Request: Revision of a currently approved information collection; Title of Information Collection: Data Collection to Support Eligibility Determinations and Enrollment for Employers in the Small Business Health Options Program; Use: Section 1311(b)(1)(B) of the Affordable Care Act directs that the SHOP assist qualified small employers in facilitating the enrollment of their employees in QHPs offered in the small group market. Section 1311(c)(1)(F) of the Affordable Care Act directs HHS to establish criteria for certification of health plans as QHPs and plans to utilize a uniform enrollment form for qualified employers. Further, section 1311(c)(5)(B) directs HHS to develop a Web site that assists employers in VerDate Sep<11>2014 14:55 Dec 10, 2015 Jkt 238001 determining if they are eligible to participate in SHOP. Form Number: CMS–10439 (OMB Control Number: 0938–1139); Frequency: Annually; Affected Public: Private Sector; Number of Respondents: 6,000; Number of Responses: 6,000; Total Annual Hours: 12,000. (For questions regarding this collection contact Christelle Jang at (410) 786–8438.) Dated: December 8, 2015. William N. Parham, III, Director, Paperwork Reduction Staff, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2015–31302 Filed 12–10–15; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director; Notice of Charter Renewal In accordance with Title 41 of the U.S. Code of Federal Regulations, Section 102–3.65(a), notice is hereby given that the Charter for the PUBMED CENTRAL NATIONAL ADVISORY COMMITTEE (PUBMED) was renewed for an additional two-year period on December 8, 2015. It is determined that the PUBMED is in the public interest in connection with the performance of duties imposed on the National Institutes of Health by law, and that these duties can best be performed through the advice and counsel of this group. Inquiries may be directed to Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy, Office of the Director, National Institutes of Health, 6701 Democracy Boulevard, Suite 1000, Bethesda, Maryland 20892 (Mail Code 4875), Telephone (301) 496– 2123, or spaethj@od.nih.gov. Dated: December 8, 2015. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–31239 Filed 12–10–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Director, Office of Science Policy, Office of Biotechnology Activities; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is PO 00000 Frm 00070 Fmt 4703 Sfmt 4703 76995 hereby given of the meeting of the National Science Advisory Board for Biosecurity (NSABB). Name of Committee: National Science Advisory Board for Biosecurity. Date: January 7–8, 2016. Time: January 7, 2016, 8:30 a.m.–5:30 p.m. Eastern; January 8, 2016, 8:30 a.m. to adjournment. Agenda: Presentations and discussions regarding: (1) Preliminary findings of the NSABB Working Group on Evaluating the Risks and Benefits of Gain-of-Function (GOF) Studies; (2) the results of the risk-benefit assessment of GOF studies involving pathogens with pandemic potential; (3) ethical and policy issues relevant to the conduct and oversight of GOF studies; and (4) other business of the Board. Place: National Institutes of Health, Bldg. 31, C Wing, 6th Floor, Conference Room 6, 9000 Rockville Pike, Bethesda, MD 20892. Contact Person: Christopher Viggiani, Ph.D., Executive Director, NSABB, NIH Office of Science Policy, 6705 Rockledge Drive, Suite 750, Bethesda, Maryland 20892, (301) 496–9838, viggianic@od.nih.gov. Under authority 42 U.S.C. 217a, Section 222 of the Public Health Service Act, as amended, the Department of Health and Human Services established the National Science Advisory Board for Biosecurity (NSABB) to provide advice regarding federal oversight of dual use research—defined as legitimate biological research that generates information and technologies that could be misused to pose a biological threat to public health and/or national security. The NSABB is currently charged with providing formal recommendations to the United States Government on a conceptual approach for the evaluation of proposed gain-of-function studies. The meeting will be open to the public and will also be webcast as space will be limited. Persons planning to attend or view via the webcast may preregister online using the link provided below or by calling Palladian Partners, Inc. (Contact: Ida Donner at 301–650– 8660). Online and telephone registration will close at 12:00 p.m. Eastern on January 4, 2016. After that time, attendees may register onsite on the day of the meeting. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should indicate these requirements upon registration on or prior to January 4. Meeting materials: The meeting agenda and links to the online registration and webcast will be available at: https://osp.od.nih.gov/ office-biotechnology-activities/ biosecurity/nsabb/nsabb-meetings-andconferences. Preliminary findings of the NSABB working group as well as the results of the risk-benefit assessment, E:\FR\FM\11DEN1.SGM 11DEN1 76996 Federal Register / Vol. 80, No. 238 / Friday, December 11, 2015 / Notices jstallworth on DSK7TPTVN1PROD with NOTICES performed by Gryphon Scientific, will be posted prior to the meeting. Please check this Web site for updates. Public Comments: Many presentations and panel discussions at the meeting will be accompanied by question and answer periods that are open to members of the public, time permitting. In addition, there will also be time allotted on the agenda for the presentation of public comments. Members of the public interested in presenting prepared comments relevant to the mission of the NSABB should indicate so upon registration. Sign-up for delivering prepared oral comments will be limited to one per person or organization representative per open comment period. Individual presentations will be time-limited to facilitate broad participation from multiple speakers. Participants viewing the meeting by webcast may submit questions and comments during the meeting via email sent to nsabb@ od.nih.gov. While time constraints and the volume of questions may not allow for all questions and comments submitted via email to be aired during the meeting, all relevant correspondence received will be relayed to the Board. Emailed correspondence should include the name, contact information, and when applicable, professional affiliation of the sender. In addition, interested persons may file written comments at any time with the Board via an email sent to nsabb@ od.nih.gov or by regular mail sent to the Contact Person listed on this notice. Written statements should include the name, contact information, and when applicable, the professional affiliation of the interested person. Written comments received by 5:00 p.m. Eastern on December 31, 2015, will be relayed to the Board prior to the NSABB meeting. Any written comments received after this deadline will be provided to the Board either before or after the meeting, depending on the volume of comments received and the time required to process them in accordance with privacy regulations and other applicable Federal policies. Please Note: In the interest of security, NIH has instituted stringent procedures for entrance onto the NIH campus. All visitor vehicles, including taxis, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors will be asked to show one form of identification (for example, a government-issued photo ID, driver’s license, or passport) and to state the purpose of their visit. Please visit the NIH Visitor Security page for important security and campus access information. VerDate Sep<11>2014 14:55 Dec 10, 2015 Jkt 238001 Dated: December 8, 2015. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–31238 Filed 12–10–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of The Director, National Institutes of Health; Notice of Meeting Notice is hereby given of a meeting of the Big Data to Knowledge MultiCouncil Working Group. The teleconference meeting will be open to the public as indicated below. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Working Group: Big Data to Knowledge Multi-Council Working Group. Date: January 11, 2015. Open: 11:00 a.m. to 12:00 p.m. Agenda: Discussion will review current Big Data to Knowledge (BD2K) activities and newly proposed BD2K initiatives. Place: Teleconference. This meeting is open to the public but is being held by teleconference only. No physical meeting location is provided for any interested individuals to listen to committee discussions. Any individual interested in listening to the meeting discussions must call: 1–866–692–3158 and use Passcode: 2956317, for access to the meeting. Closed: 12:10 p.m.–3:30 p.m. Agenda: Discussion will focus on review of proposed Funding Plans for BD2K Funding Opportunity Announcements. Place: Teleconference. Contact Person: Tonya Scott, email: tonya.scott@nih.gov, phone: 301–402– 9817. Information is also available on the Office of the Associate Director for Data Science’s home page: https:// datascience.nih.gov/index where an agenda and any additional information for the meeting will be posted when available. Dated: December 7, 2015. Anna Snouffer, Deputy Director, Office of Federal Advisory Committee Policy. [FR Doc. 2015–31162 Filed 12–10–15; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00071 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group; Clinical, Treatment and Health Services Review Subcommittee (AA– 3). Date: March 15, 2016. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: NIAAA, NIH, 5635 Fishers Lane, Terrace Level, Room 508/509, Rockville, MD 20852. Contact Person: Katrina L. Foster, Ph.D., Scientific Review Officer, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Lane, Room 2019, Rockville, MD 20852, 301–443–4032, katrina@mail.nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group; Epidemiology, Prevention and Behavior Research Review Subcommittee (AA–2). Date: March 21, 2016. Time: 8:30 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: NIAAA, NIH, 5635 Fishers Lane, Terrace Level, Room 508/509, Rockville, MD 20852. Contact Person: Katrina L. Foster, Ph.D., Scientific Review Officer, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 Fishers Lane, Room 2019, Rockville, MD 20852, 301–443–3037, katrina@mail.nih.gov, (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) E:\FR\FM\11DEN1.SGM 11DEN1

Agencies

[Federal Register Volume 80, Number 238 (Friday, December 11, 2015)]
[Notices]
[Pages 76995-76996]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-31238]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Office of the Director, Office of Science Policy, Office of 
Biotechnology Activities; Notice of Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the meeting of the 
National Science Advisory Board for Biosecurity (NSABB).

    Name of Committee: National Science Advisory Board for 
Biosecurity.
    Date: January 7-8, 2016.
    Time: January 7, 2016, 8:30 a.m.-5:30 p.m. Eastern; January 8, 
2016, 8:30 a.m. to adjournment.
    Agenda: Presentations and discussions regarding: (1) Preliminary 
findings of the NSABB Working Group on Evaluating the Risks and 
Benefits of Gain-of-Function (GOF) Studies; (2) the results of the 
risk-benefit assessment of GOF studies involving pathogens with 
pandemic potential; (3) ethical and policy issues relevant to the 
conduct and oversight of GOF studies; and (4) other business of the 
Board.
    Place: National Institutes of Health, Bldg. 31, C Wing, 6th 
Floor, Conference Room 6, 9000 Rockville Pike, Bethesda, MD 20892.
    Contact Person: Christopher Viggiani, Ph.D., Executive Director, 
NSABB, NIH Office of Science Policy, 6705 Rockledge Drive, Suite 
750, Bethesda, Maryland 20892, (301) 496-9838, viggianic@od.nih.gov.

    Under authority 42 U.S.C. 217a, Section 222 of the Public Health 
Service Act, as amended, the Department of Health and Human Services 
established the National Science Advisory Board for Biosecurity (NSABB) 
to provide advice regarding federal oversight of dual use research--
defined as legitimate biological research that generates information 
and technologies that could be misused to pose a biological threat to 
public health and/or national security. The NSABB is currently charged 
with providing formal recommendations to the United States Government 
on a conceptual approach for the evaluation of proposed gain-of-
function studies.
    The meeting will be open to the public and will also be webcast as 
space will be limited. Persons planning to attend or view via the 
webcast may pre-register online using the link provided below or by 
calling Palladian Partners, Inc. (Contact: Ida Donner at 301-650-8660). 
Online and telephone registration will close at 12:00 p.m. Eastern on 
January 4, 2016. After that time, attendees may register onsite on the 
day of the meeting. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should indicate these requirements upon registration on 
or prior to January 4.
    Meeting materials: The meeting agenda and links to the online 
registration and webcast will be available at: https://osp.od.nih.gov/office-biotechnology-activities/biosecurity/nsabb/nsabb-meetings-and-conferences. Preliminary findings of the NSABB working group as well as 
the results of the risk-benefit assessment,

[[Page 76996]]

performed by Gryphon Scientific, will be posted prior to the meeting. 
Please check this Web site for updates.
    Public Comments: Many presentations and panel discussions at the 
meeting will be accompanied by question and answer periods that are 
open to members of the public, time permitting. In addition, there will 
also be time allotted on the agenda for the presentation of public 
comments. Members of the public interested in presenting prepared 
comments relevant to the mission of the NSABB should indicate so upon 
registration. Sign-up for delivering prepared oral comments will be 
limited to one per person or organization representative per open 
comment period. Individual presentations will be time-limited to 
facilitate broad participation from multiple speakers. Participants 
viewing the meeting by webcast may submit questions and comments during 
the meeting via email sent to nsabb@od.nih.gov. While time constraints 
and the volume of questions may not allow for all questions and 
comments submitted via email to be aired during the meeting, all 
relevant correspondence received will be relayed to the Board. Emailed 
correspondence should include the name, contact information, and when 
applicable, professional affiliation of the sender.
    In addition, interested persons may file written comments at any 
time with the Board via an email sent to nsabb@od.nih.gov or by regular 
mail sent to the Contact Person listed on this notice. Written 
statements should include the name, contact information, and when 
applicable, the professional affiliation of the interested person. 
Written comments received by 5:00 p.m. Eastern on December 31, 2015, 
will be relayed to the Board prior to the NSABB meeting. Any written 
comments received after this deadline will be provided to the Board 
either before or after the meeting, depending on the volume of comments 
received and the time required to process them in accordance with 
privacy regulations and other applicable Federal policies.

    Please Note: In the interest of security, NIH has instituted 
stringent procedures for entrance onto the NIH campus. All visitor 
vehicles, including taxis, hotel, and airport shuttles will be 
inspected before being allowed on campus. Visitors will be asked to 
show one form of identification (for example, a government-issued 
photo ID, driver's license, or passport) and to state the purpose of 
their visit. Please visit the NIH Visitor Security page for 
important security and campus access information.


    Dated: December 8, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-31238 Filed 12-10-15; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.